Cardigant Medical Inc  

(Public, OTCBB:CARD)   Watch this stock  
0.0000
Delayed:  
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol / Avg. 0.00/0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -0.01
Shares 23.26M
Beta     -
Inst. own     -

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -1494.36% -481.65%
Return on average equity - -
Employees 3 -
CDP Score - -

Address

SUITE 500, 1500 ROSECRANS AVENUE
MANHATTAN BEACH, CA 90266
United States - Map
+1-310-4218654 (Phone)
+1-302-2669940 (Fax)

Description

Cardigant Medical Inc. is a development-stage biotechnology company. The Company focuses on the use of biologics and combination biologics and devices for the treatment of acute coronary syndromes (ACS) and aortic valve stenosis (AVS). The Company focuses on local drug delivery for the treatment of cardiovascular and peripheral vascular disease. Its primary focus is on treating atherosclerosis and plaque stabilization in both the coronary and peripheral vasculature, as well as stenosis of the aortic valve using systemic delivery of large molecule therapeutics based on high density lipoprotein (HDL) targets. The Company´┐Żs also focuses on the use of targeted local delivery to reduce systemic exposure and drug dosage. The Company uses a synthetically modified protein based on the Apolipoprotein A-I (Apoa-1) structure, which is found in HDL.

Officers and directors

William M. Pinon Chairman of the Board
Age: 48
Jerett A. Creed President, Chief Executive Officer, Interim Chief Financial Officer, Director
Age: 39
Ralph M. Sinibaldi Ph.D. Vice President, Chief Scientific Officer
Age: 65
Emerson C. Perin M.D., Ph.D. Chief Medical Officer
Age: 53
Scott Merz Ph.D. Director
Age: 48